Catalent Stock (NYSE: CTLT) stock price, news, charts, stock research, profile.
Open | $56.000 |
Close | $56.030 |
Volume / Avg. | 1.576M / 2.703M |
Day Range | 55.830 - 56.190 |
52 Wk Range | 31.450 - 60.200 |
Market Cap | $10.140B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 47 |
Short Interest | 5.3% |
Days to Cover | 4.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Catalent (NYSE: CTLT) through any online brokerage.
Other companies in Catalent’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Catalent (NYSE: CTLT) was reported by Stephens & Co. on Thursday, April 4, 2024. The analyst firm set a price target for 63.50 expecting CTLT to rise to within 12 months (a possible 13.33% upside). 41 analyst firms have reported ratings in the last year.
The stock price for Catalent (NYSE: CTLT) is $56.03 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Catalent.
Catalent’s Q3 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Catalent.
Catalent is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.